secwatch.observer — SEC 8-K summary
======================================

Issuer:     CVRx, Inc. (CVRX)
CIK:        0001235912
Form:       8-K
Filed at:   2023-10-26T23:59:59+00:00
Accession:  0001104659-23-111750
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CVRx Q3 revenue up 70% to $10.5M, raises FY2023 revenue guidance
----------------------------------------------------------------

- Revenue $10.5M (+70% YoY); U.S. HF revenue $9.4M (+92% YoY).
- Net loss $9.0M ($0.43/sh) vs $9.8M ($0.48/sh) in Q3 2022; cash burn improved to $8.2M from $13.0M in Q2.
- Active implanting centers 159 (+75% YoY); sales territories grew to 35.
- FY2023 revenue guidance raised to $38.5M-$39.0M (from $37.0M-$38.5M); Q4 revenue expected $10.5M-$11.0M.
- CMS advisory panel unanimously recommended higher Barostim payment code; final rule expected late Nov.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1235912/000110465923111750/0001104659-23-111750-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1235912/000110465923111750/tm2329194d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-111750

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer